← FDA Drug Approvals (Drugs@FDA)

OBREDON

NDA · New Drug Application · Sponsor: SOVEREIGN PHARMS · Approved 2014-11-14

Drug application

FDA Application #

NDA205474

Application type

New Drug Application

Brand name

OBREDON

Generic name

Guaifenesin

Active ingredients

GUAIFENESIN; HYDROCODONE BITARTRATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

SOVEREIGN PHARMS

First approval

2014-11-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown